跳至主要内容
临床试验/NCT00230204
NCT00230204Unknown1 期

Antibodies Screening in Multiple Sclerosis as a Part of an International Survey in Autoimmune Diseases.

Sheba Medical Center2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2005年9月最近更新:
适应症

试验速览

阶段
1 期
入组人数
100
试验地点
2
主要终点
Determine antibodies to infectious agents immunoglobulin G (IgG), IgM in patients with multiple sclerosis

研究概览

简要总结

The purpose of this investigation is to assess the prevalence of infectious disease seropositivity (toxoplasmosis, rubella, cytomegalovirus [CMV]), herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2), syphilis, Epstein-Barr virus and H. pylori in a group of patients presenting with specific autoimmune diseases (rheumatoid arthritis [RA], undifferentiated connective tissue disorder [UCTD], Sjogren, antiphospholipid syndrome - APS, vasculitides, systemic lupus erythematosus [SLE], polymyositis, Hashimoto, multiple sclerosis, primary biliary cirrhosis [PBC], etc.), using the BioPlex 2200 and complementary EIA kits as compared to matched controls (by age, sex and ethnicity).

详细描述

The purpose of this investigation is to assess the prevalence of infectious disease seropositivity (toxoplasmosis, rubella, cytomegalovirus [CMV]), herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2), syphilis, Epstein-Barr virus and H. pylori in a group of patients presenting with specific autoimmune diseases (RA, UCTD, Sjogren, antiphospholipid syndrome - APS, vasculitides, SLE, polymyositis, Hashimoto, multiple sclerosis, PBC, etc.), using the BioPlex 2200 and complementary EIA kits as compared to matched controls (by age, sex and ethnicity).

We will assess in our Center 100 patients with multiple sclerosis for the antibody profile of different infectious agents. Comparative assessments will be performed with normal matched subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Definite multiple sclerosis

排除标准

  • Intravenous immune globulin (IVIg) treatment

结局指标

主要结局

Determine antibodies to infectious agents immunoglobulin G (IgG), IgM in patients with multiple sclerosis

次要结局

  • Assess correlation between antibody levels to various infectious agents with clinical disease variables

研究者

申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验